Results 21 to 30 of about 147 (124)

Aprecierea stadiului tumorii și a volumului operației în cancerul căilor biliare extrahepatice și al papilei Vater [PDF]

, 2020
Background. Cancer of the extrahepatic bile ducts and papilla Vater occupies the 20th place (0.4% o) in the structure of oncological morbidity in the Republic of Moldova.
Ostahi, Nadia
core  

Pattern and Clinical Significance of CA19‐9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Carbohydrate antigen 19–9 (CA19‐9) is a cell surface glycoprotein widely used as a diagnostic and prognostic serum marker for monitoring pancreatic cancer. The aim of this study was to evaluate the prevalence and clinical relevance of CA19‐9 expression in human cancer. Methods To comprehensively determine the prevalence and clinical
Nina Schraps, Anne Menz, Florian Viehweger, Seyma Büyücek, David Dum, Ria Schlichter, Andrea Hinsch, Christoph Fraune, Christian Bernreuther, Martina Kluth, Claudia Hube‐Magg, Katharina Möller, Viktor Reiswich, Andreas M. Luebke, Patrick Lebok, Sören Weidemann, Guido Sauter, Maximilian Lennartz, Frank Jacobsen, Till S. Clauditz, Andreas H. Marx, Ronald Simon, Stefan Steurer, Baris Mercanoglu, Nathaniel Melling, Thilo Hackert, Eike Burandt, Natalia Gorbokon, Sarah Minner, Till Krech, Florian Lutz, Morton Freytag   +31 more
wiley   +1 more source

A Case of Bilio‐Bronchial Fistula Presenting With Bilioptysis Following Hepatocellular Carcinoma Treatment

Respirology Case Reports, Volume 14, Issue 1, January 2026.
We present a detailed case of a bilio‐bronchial fistula that developed in a complex, multitreated HCC patient, illustrating a plausible causal chain from liver resection and ablation to fistula formation. This report underscores bilio‐bronchial fistula as a potential late complication of hepatic ablative therapy, highlights the critical importance of ...
Chin‐Tong Kwok, Kar‐Vin Chan, Sai‐On Ling, Patrick Tam, Cee‐Kin Tseng, Yiu‐Fai Cheung, Chie‐Wai Yim, Thomas Mok, Chi‐Hung Lau, Hoi‐Yee Kwan   +9 more
wiley   +1 more source

A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer

, 2017
PURPOSE: Combination chemotherapy with gemcitabine and cisplatin is a standard treatment for patients with advanced biliary tract cancer.
박승우, 방승민, 송시영, 이승우, 성진실   +4 more
core   +1 more source

Desmoid Tumor of the Porta Hepatis: A Rare Location With Unusual Clinical Presentation

Case Reports in Hepatology, Volume 2026, Issue 1, 2026.
Background Desmoid tumor is a locally aggressive fibroblastic/myofibroblastic neoplasm frequently arising in deep soft tissues. Although it can be well circumscribed, a desmoid tumor generally infiltrates surrounding tissues and tends to recur locally without metastasizing.
Adila Adilli, Altay Aliyev, Yıldırım Karslıoğlu, Gulen Bulbul Dogusoy, Eldar Ahmadov, Parvana Asgarova, Farida Agayarlı, Iqbal Babazade, Arturan Ibrahimli, Gunel Ziyadova, Sreeja Dattachoudhury   +10 more
wiley   +1 more source

Tumor de Klatskin. Presentación de un paciente [PDF]

, 2007
Klatskin's tumor usually presents as a diffuse nodular lesion, being refered to as colangiocarcinoma. It originates at the confluence of both hepatic ducts. This fact imposes the need of peering at hepatic ducts proximally in colangiography.
López Soler, Julio C., de Armas Prado, Jesús Isaac, Ibáñez Bravo, Luis Alberto   +2 more
core   +1 more source

Magnetic resonance imaging of cholangiocarcinoma

, 2004
Cholangiocarcinoma arises from the bile ducts and is the most common primary malignancy of the biliary tree. Cholangiocarcinoma is classified according to its growth pattern: mass-forming, periductal-infiltrating, or intraductal-growing type.
Vecchioli A, Barbaro B, Masselli G, MANFREDI, Riccardo, Marano P.   +4 more
core   +1 more source

Radiotherapy or chemoradiation in unresectable biliary cancer: A retrospective study

, 2019
Background/Aim: To retrospectively evaluate the outcome of patients with unresectable biliary cholangiocarcinoma (CC) treated with radiotherapy (RT) plus/minus chemotherapy (CHT).
Cellini F., Cilla S., Bisello S., Brandi G., Morganti A. G., Deodato F., Cammelli S., Autorino R., Valentini V., Buwenge M., Macchia G., Tagliaferri L., Mattiucci G. C., Palloni A.   +13 more
core   +1 more source

Prognosis and Chemotherapeutic Efficacy in Extrahepatic Cholangiocarcinoma With Lung Metastases

Cancer Reports, Volume 8, Issue 5, May 2025.
ABSTRACT Objective Studies on lung metastases from extrahepatic cholangiocarcinoma (ECC) are rare. This study aims to fill this gap by analyzing the influencing factors, prognosis, and chemotherapeutic efficacy of ECC lung metastases, and to provide insights for optimizing medical care for patients with ECC lung metastases.
Chao Zhang, Shun Tu, Yanting Liao, Yaqiang Shu, Muyu Fu, Jiayue Li, Xiaohua Lei   +6 more
wiley   +1 more source

Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 5, May 2025.
ABSTRACT Background The absence of validated methods to identify cholangiocarcinoma in real‐world data has prevented the conduct of pharmacoepidemiologic studies to evaluate determinants of this malignancy and examine the effectiveness of cholangiocarcinoma treatments.
Nicole D. Ferrante, Rebecca A. Hubbard, Kelley Weinfurtner, Anya I. Mezina, Craig W. Newcomb, Emma E. Furth, Debika Bhattacharya, Basile Njei, Tamar H. Taddei, Amit Singal, Maarouf A. Hoteit, Lesley S. Park, David Kaplan, Vincent Lo Re III   +13 more
wiley   +1 more source